Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection

Ítems similars

• Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
  per: Moraes, Carolina B., et al.
  Publicat: (2014)
• A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity
  per: Laura M. Alcântara, et al.
  Publicat: (2020-05-01)
• A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity
  per: Alcântara, Laura M., et al.
  Publicat: (2020)
• Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes
  per: Matutino Bastos, Tanira, et al.
  Publicat: (2020)
• Identification of Inhibitors to <i>Trypanosoma cruzi</i> Sirtuins Based on Compounds Developed to Human Enzymes
  per: Tanira Matutino Bastos, et al.
  Publicat: (2020-05-01)